First Eagle Investment Management, LLC - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 89 filers reported holding ANTARES PHARMA INC in Q1 2014. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.

Quarter-by-quarter ownership
First Eagle Investment Management, LLC ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q4 2017$100,000
-38.3%
50,0000.0%0.00%
Q3 2017$162,000
+153.1%
50,000
+150.0%
0.00%
Q2 2017$64,000
+12.3%
20,0000.0%0.00%
Q1 2017$57,000
+21.3%
20,0000.0%0.00%
Q4 2016$47,000
+38.2%
20,0000.0%0.00%
Q3 2016$34,000
+61.9%
20,0000.0%0.00%
Q2 2016$21,000
+23.5%
20,0000.0%0.00%
Q1 2016$17,000
-29.2%
20,0000.0%0.00%
Q4 2015$24,000
-29.4%
20,0000.0%0.00%
Q3 2015$34,000
-19.0%
20,0000.0%0.00%
Q2 2015$42,000
-22.2%
20,0000.0%0.00%
Q1 2015$54,000
+5.9%
20,0000.0%0.00%
Q4 2014$51,000
+37.8%
20,0000.0%0.00%
Q3 2014$37,000
-30.2%
20,0000.0%0.00%
Q2 2014$53,000
-24.3%
20,0000.0%0.00%
Q1 2014$70,000
-22.2%
20,0000.0%0.00%
Q4 2013$90,000
+11.1%
20,0000.0%0.00%
Q3 2013$81,000
-2.4%
20,0000.0%0.00%
Q2 2013$83,00020,0000.00%
Other shareholders
ANTARES PHARMA INC shareholders Q1 2014
NameSharesValueWeighting ↓
JW Asset Management, LLC 1,671,956$5,384,0003.43%
ARMISTICE CAPITAL, LLC 5,700,000$18,354,0002.34%
Rubric Capital Management LP 3,188,600$10,267,0002.12%
Broadfin Capital, LLC 4,803,528$15,467,0001.88%
THOMPSON DAVIS & CO., INC. 192,734$621,0001.00%
Asymmetry Capital Management, L.P. 199,655$643,0000.76%
Perceptive Advisors 4,267,253$13,741,0000.69%
KINGDON CAPITAL MANAGEMENT, L.L.C. 946,987$3,049,0000.21%
Brown Advisory Securities, LLC 275,000$886,0000.20%
EAM Investors, LLC 251,619$810,0000.13%
View complete list of ANTARES PHARMA INC shareholders